Annual EBITDA
$4.57B$163.00M-3.44%
Summary
- Current Value
- As of today, VTRS annual EBITDA is $4.57B, down -3.44% on
- Historical Performance
- VTRS annual EBITDA is down -6.35% over the past 3 years, and up +61.92% over the past 5 years
- All-Time High Comparison
- VTRS annual EBITDA is currently -14.80% below its historical high of $5.36B set on
- 3-Year Low Comparison
- VTRS annual EBITDA is at its 3-year low
- Sector Comparison
- VTRS annual EBITDA is higher than 97.63% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.57B | -3.4% | -6.3% | +61.9% | +290.7% | |
| Quarterly EBITDA | $1.01B | -13.2% | -21.5% | +13.1% | +191.3% | |
| TTM EBITDA | $3.79B | -10.2% | -27.5% | +22.4% | +203.2% | |
| Price | $12.46 | +3.8% | +3.0% | -32.7% | -44.2% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $14.71B | -4.4% | -17.6% | +27.9% | +188.8% | |
| Annual EPS | -$0.53 | -1273.3% | +49.4% | -1735.4% | -277.2% | |
| Annual EBIT | $1.86B | -9.4% | +11.6% | +89.3% | +142.2% | |
| Annual Net Income | -$634.20M | -1259.4% | +50.0% | -3875.0% | -356.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.36B | N/A | -14.8% |
| 5Y | $5.36B | -14.8% | |
| All | $5.36B | -14.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.57B | at low | |
| 5Y | $3.57B | N/A | +27.8% |
| All | $2.32M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of VTRS?
As of today, VTRS annual EBITDA is $4.57B
What is 1-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -3.44% year-over-year
What is 3-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -6.35% over the past 3 years
How far is VTRS annual EBITDA from its all-time high?
VTRS annual EBITDA is currently -14.80% below its historical high of $5.36B set on December 31, 2022
How does VTRS annual EBITDA rank versus sector peers?
VTRS annual EBITDA is higher than 97.63% of companies in Healthcare sector
When is VTRS next annual earnings release?
The next annual earnings release for VTRS is on
Quarterly EBITDA
$1.01B$32.10M-3.09%
Summary
- Current Value
- As of today, VTRS quarterly EBITDA is $1.01B, down -3.09% on
- Historical Performance
- VTRS quarterly EBITDA is down -13.24% year-over-year, and down -21.46% over the past 3 years
- All-Time High Comparison
- VTRS quarterly EBITDA is currently -40.30% below its historical high of $1.68B set on
- 3-Year Low Comparison
- VTRS quarterly EBITDA is +28.01% above its 3-year low of $785.80M reached on
- Sector Comparison
- VTRS quarterly EBITDA is higher than 96.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.01B | -3.1% | -13.2% | -21.5% | +13.1% | |
| Annual EBITDA | $4.57B | – | -3.4% | -6.3% | +61.9% | |
| TTM EBITDA | $3.79B | -3.9% | -10.2% | -27.5% | +22.4% | |
| Price | $12.46 | +22.9% | +3.8% | +3.0% | -32.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $3.76B | +5.0% | +0.1% | -7.0% | +26.6% | |
| Quarterly EPS | -$0.11 | -2723.1% | -239.4% | -137.8% | -130.7% | |
| Quarterly EBIT | $317.40M | -11.8% | -35.2% | -45.4% | -30.6% | |
| Quarterly Net Income | -$128.20M | -2687.0% | -235.2% | -136.2% | -169.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | -3.1% | |
| 3Y | $1.39B | N/A | -27.8% |
| 5Y | $1.68B | -40.3% | |
| All | $1.68B | -40.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $841.70M | +19.5% | |
| 3Y | $785.80M | +28.0% | |
| 5Y | $785.80M | +28.0% | |
| All | -$56.49M | +1880.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of VTRS?
As of today, VTRS quarterly EBITDA is $1.01B
What is VTRS quarterly EBITDA most recent change?
VTRS quarterly EBITDA was down -3.09% on September 30, 2025
What is 1-year change in VTRS quarterly EBITDA?
VTRS quarterly EBITDA is down -13.24% year-over-year
How far is VTRS quarterly EBITDA from its all-time high?
VTRS quarterly EBITDA is currently -40.30% below its historical high of $1.68B set on June 30, 2021
How does VTRS quarterly EBITDA rank versus sector peers?
VTRS quarterly EBITDA is higher than 96.93% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
TTM EBITDA
$3.79B$153.50M-3.90%
Summary
- Current Value
- As of today, VTRS TTM EBITDA is $3.79B, down -3.90% on
- Historical Performance
- VTRS TTM EBITDA is down -10.18% year-over-year, and down -27.49% over the past 3 years
- All-Time High Comparison
- VTRS TTM EBITDA is currently -38.95% below its historical high of $6.20B set on
- 3-Year Low Comparison
- VTRS TTM EBITDA is +2.68% above its 3-year low of $3.69B reached on
- Sector Comparison
- VTRS TTM EBITDA is higher than 97.02% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.79B | -3.9% | -10.2% | -27.5% | +22.4% | |
| Annual EBITDA | $4.57B | – | -3.4% | -6.3% | +61.9% | |
| Quarterly EBITDA | $1.01B | -3.1% | -13.2% | -21.5% | +13.1% | |
| Price | $12.46 | +22.9% | +3.8% | +3.0% | -32.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $14.06B | +0.0% | -6.4% | -15.5% | +22.1% | |
| TTM EPS | -$3.10 | -6.5% | -319.3% | -569.5% | -701.8% | |
| TTM EBIT | $1.01B | -14.6% | -29.2% | -56.4% | -27.5% | |
| TTM Net Income | -$3.69B | -6.4% | -317.9% | -559.4% | -1485.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.94B | N/A | -4.0% |
| 3Y | $5.44B | N/A | -30.4% |
| 5Y | $6.20B | -39.0% | |
| All | $6.20B | -39.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.69B | +2.7% | |
| 3Y | $3.69B | +2.7% | |
| 5Y | $3.22B | N/A | +17.7% |
| All | -$56.49M | +6803.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of VTRS?
As of today, VTRS TTM EBITDA is $3.79B
What is VTRS TTM EBITDA most recent change?
VTRS TTM EBITDA was down -3.90% on September 30, 2025
What is 1-year change in VTRS TTM EBITDA?
VTRS TTM EBITDA is down -10.18% year-over-year
How far is VTRS TTM EBITDA from its all-time high?
VTRS TTM EBITDA is currently -38.95% below its historical high of $6.20B set on December 31, 2021
How does VTRS TTM EBITDA rank versus sector peers?
VTRS TTM EBITDA is higher than 97.02% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1792044/000179204425000046/0001792044-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204425000008/0001792044-25-000008-index.htm
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs